Transfer of tumor immunity by both CD4+ and CD8+ tumor infiltrating T lymphocytes activated in vivo by IL-2 therapy of tumor bearing mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transfer of tumor immunity by both CD4+ and CD8+ tumor infiltrating T lymphocytes activated in vivo by IL-2 therapy of tumor bearing mice

Published:1993-07 Issue:3 Volume:188 Page:281-292
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Maas Riks A.,Becker Martin J.,Weimar Iris S.,De Nooy Joriene C.,Dullens Hub F.J.,Den Otter Willem

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference27 articles.

1. Eradication of disseminated murine leukemia by treatment with high dose interleukin 2;Thompson;J. Immunol.,1986

2. Local and systemic effects during interleukin-2 therapy of mouse mammary tumors;Vaage;Cancer Res.,1987

3. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients;Rosenberg;Ann. Surg.,1989

4. Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study;Parkinson;J. Clin. Oncol.,1990

5. Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2;Maas;Cancer Res.,1989

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential requirements of CD4+T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8+T-cell precursor frequency;Immunology;2013-03-11

2. The effect of interleukin-2 on canine peripheral nerve sheath tumours after marginal surgical excision: a double-blind randomized study;BMC Veterinary Research;2013

3. CD40 ligation restores cytolytic T lymphocyte response and eliminates fibrosarcoma in the peritoneum of mice lacking CD4+ T cells;Cancer Immunology, Immunotherapy;2006-02-21

4. Local interleukin 2 therapy is most effective against cancer when injected intratumourally;Cancer Immunology, Immunotherapy;2005-02-01

5. Interleukin 2 (IL-2) therapy: potential advantages of locoregional versus systemic administration;Cancer Treatment Reviews;1999-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3